Gilead Sciences Inc. (GILD)

Index:

Nasdaq 100

$ 118.84
   
  • Change Today:
    $-4.56
  • 52 Week High: $124.08
  • 52 Week Low: $87.75
  • Currency: US Dollars
  • Shares Issued: 1,246.00m
  • Volume: 9,065,499
  • Market Cap: $148,075m
  • RiskGrade: 120

Latest ShareCast News

GSK's ViiV says trial indicates HIV shot as effective as rival Gilead pill

By Frank Prenesti

Date: Thursday 23 Feb 2023

(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GILD Market Data

Currency US Dollars
Share Price $ 118.84
Change Today $ -4.56
% Change -3.70 %
52 Week High $124.08
52 Week Low $87.75
Volume 9,065,499
Shares Issued 1,246.00m
Market Cap $148,075m
RiskGrade 120

What The Brokers Say

Strong Buy 9
Buy 12
Neutral 6
Sell 1
Strong Sell 0
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 07-Nov-2025

Time Volume / Share Price
15:59 231 @ $118.84
15:59 150 @ $118.86
15:59 100 @ $118.82
15:59 100 @ $118.83
15:59 100 @ $118.83

Top of Page